Clinical Trials Logo

Kidney Impairment clinical trials

View clinical trials related to Kidney Impairment.

Filter by:
  • None
  • Page 1

NCT ID: NCT06248567 Recruiting - Kidney Impairment Clinical Trials

Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease

Start date: January 15, 2024
Phase: Phase 1
Study type: Interventional

This study will assess the effect of severe kidney impairment on the pharmacokinetics (PK), safety and tolerability of ZSP1273.

NCT ID: NCT06160622 Completed - Kidney Impairment Clinical Trials

Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease

Start date: September 26, 2023
Phase: Phase 1
Study type: Interventional

This study will assess the effect of severe kidney impairment on the pharmacokinetics (PK), safety and tolerability of Leritrelvir.

NCT ID: NCT04308642 Completed - Kidney Impairment Clinical Trials

Study to Evaluate Blood and Urine Kidney Injury Markers to Facilitate Early Detection of Renal Adverse Drug Events in Pediatric Cancer Patients Treated With Nephrotoxic Chemotherapy

Kid-MaCareOnco
Start date: October 22, 2020
Phase:
Study type: Observational

This study is to investigate blood and urine kidney injury markers (especially Uromodulin) in pediatric cancer patients treated with nephrotoxic chemotherapy. Uromodulin is a marker to detect and monitor tubular injury and renal function.